Outcomes of Patients With Catecholaminergic Polymorphic Ventricular Tachycardia Treated With β-Blockers.
Sign Up to like & getrecommendations! Published in 2022 at "JAMA cardiology"
DOI: 10.1001/jamacardio.2022.0219
Abstract: Importance Patients with catecholaminergic polymorphic ventricular tachycardia (CPVT) may experience life-threatening arrhythmic events (LTAEs) despite β-blocker treatment. Further complicating management, the role of implantable cardioverter defibrillator (ICD) in CPVT is debated. Objective To investigate the… read more here.
Keywords: cardiology; ventricular tachycardia; icd; risk ... See more keywords
Long-term impact of β-blocker in elderly patients without myocardial infarction after percutaneous coronary intervention.
Sign Up to like & getrecommendations! Published in 2021 at "ESC heart failure"
DOI: 10.1002/ehf2.13715
Abstract: AIMS Little is known about the long-term outcomes of β-blockers use in patients with coronary artery disease (CAD) without myocardial infarction (MI) and reduced ejection fraction (rEF). However, more attention should be paid to the… read more here.
Keywords: long term; blocker group; blocker; elderly patients ... See more keywords
Dual mTORC1/mTORC2 blocker as a possible therapy for tauopathy in cellular model
Sign Up to like & getrecommendations! Published in 2017 at "Metabolic Brain Disease"
DOI: 10.1007/s11011-017-0137-7
Abstract: Tauopathy comprises a group of disorders caused by abnormal aggregates of tau protein. In these disorders phosphorylated tau protein tends to accumulate inside neuronal cells (soma) instead of the normal axonal distribution of tau. A… read more here.
Keywords: tau; cellular model; blocker; mtor ... See more keywords
Feasibility and Association of Neurohumoral Blocker Up-titration After Cardiac Resynchronization Therapy.
Sign Up to like & getrecommendations! Published in 2017 at "Journal of cardiac failure"
DOI: 10.1016/j.cardfail.2017.03.001
Abstract: BACKGROUND Cardiac resynchronization therapy (CRT) improves mortality and morbidity on top of optimal medical therapy in heart failure with reduced ejection fraction (HFrEF). This study aimed to elucidate the association between neurohumoral blocker up-titration after… read more here.
Keywords: titration; crt implantation; blocker; therapy ... See more keywords
Dose Response Relationship of RAS Blocker and beta-Blocker in Patients with Acute Heart Failure Syndrome: Data from the Korean Acute Hart Failure (KorAHF) Registry
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Cardiac Failure"
DOI: 10.1016/j.cardfail.2019.07.411
Abstract: Background Whether patients with acute heart failure syndrome (AHFS) need to reach the target dose of renin-angiotensin-system (RAS) blocker and beta-blocker to obtain a benefit in terms of clinical outcome remain uncertain. We aimed to… read more here.
Keywords: blocker; blocker beta; failure; ras blocker ... See more keywords
The Combination of Beta Blockers and Renin-Angiotensin System Blockers Improves Survival in Incident Hemodialysis Patients: A Propensity-Matched Study
Sign Up to like & getrecommendations! Published in 2017 at "Kidney International Reports"
DOI: 10.1016/j.ekir.2017.03.001
Abstract: Introduction Although several studies suggest that the prognosis of hypertensive dialysis patients can be improved by using antihypertensive drug therapy, it is unknown whether the prescription of a particular class or combination of antihypertensive drugs… read more here.
Keywords: combination; ras blocker; blocker; hemodialysis patients ... See more keywords
Combination Therapy with Alpha-blocker and Phosphodiesterase-5 Inhibitor for Improving Lower Urinary Tract Symptoms and Erectile Dysfunction in Comparison with Monotherapy: A Systematic Review and Meta-analysis.
Sign Up to like & getrecommendations! Published in 2019 at "European urology focus"
DOI: 10.1016/j.euf.2019.05.007
Abstract: CONTEXT The effects of combination therapy consisted of an α-blocker and a phosphodiesterase-5 inhibitor (PDE5I) for the treatment of lower urinary tract symptoms (LUTS) and erectile dysfunction (ED). OBJECTIVE To systematically investigate the efficacy and… read more here.
Keywords: combination; combination therapy; blocker; meta analysis ... See more keywords
Dose-dependent efficacy of β-blocker in patients with chronic heart failure and atrial fibrillation.
Sign Up to like & getrecommendations! Published in 2018 at "International journal of cardiology"
DOI: 10.1016/j.ijcard.2018.08.012
Abstract: BACKGROUND The usefulness of β-blockers in heart failure (HF) patients with permanent atrial fibrillation (AF) has been questioned. METHODS AND RESULTS We analyzed data from HF patients (958 patients (801 males, 84%, age 67 ± 11 years)) with… read more here.
Keywords: atrial fibrillation; blocker; heart; heart failure ... See more keywords
Effect of β-Blocker Withdrawal on Functional Capacity in Heart Failure and Preserved Ejection Fraction.
Sign Up to like & getrecommendations! Published in 2021 at "Journal of the American College of Cardiology"
DOI: 10.1016/j.jacc.2021.08.073
Abstract: BACKGROUND Chronotropic incompetence has shown to be associated with a decrease in exercise capacity in heart failure with preserved ejection fraction (HFpEF), yet β-blockers are commonly used in HFpEF despite the lack of robust evidence.… read more here.
Keywords: peak vo2; heart; capacity; blocker ... See more keywords
Therapeutic effect of beta‐blocker in patients with traumatic brain injury: A systematic review and meta‐analysis
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Critical Care"
DOI: 10.1016/j.jcrc.2017.05.035
Abstract: Objective: &bgr;‐Blocker exposure has been shown to reduce mortality in traumatic brain injury (TBI); however, the efficacy of &bgr;‐blockers remains inconclusive. Therefore, a meta‐analysis was conducted in this paper to evaluate the safety and efficacy… read more here.
Keywords: bgr blocker; blocker; blocker therapy; meta analysis ... See more keywords
Aggressive beta-blocker titration in stabilized acute heart failure patients with low left ventricular ejection fraction
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Taibah University Medical Sciences"
DOI: 10.1016/j.jtumed.2021.02.012
Abstract: Objectives A beta-blocker should be initiated in patients with stable acute heart failure (AHF). Beta-blocker titration should be conducted after a two-week interval. The benefits of aggressive beta-blocker titration are still unclear. This study aimed… read more here.
Keywords: blocker; beta blocker; blocker titration; aggressive beta ... See more keywords